Buhot, MC, Martin, S, Segu, L. Role of serotonin in memory impairment. Ann Med. 2000; 32(3): 210–221.
Marazziti, D, Marracci, S, Palego, L, et al. Localization and gene expression of serotonin 1A (5HT1A) receptors in human brain postmortem. Brain Res. 1994; 658(1–2): 55–59.
Yasuno, F, Suhara, T, Nakayama, T, et al. . Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory. Am J Psychiatry. 2003; 160(2): 334–340.
Steckler, T, Sahgal, A. The role of serotonergic–cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res. 1995; 67(2): 165–199.
Meneses, A. 5-HT system and cognition. Neurosci Biobehav Rev. 1999; 23(8): 1111–1125.
Ogren, S, Eriksson, T, Elvander-Tottie, E, et al. The role of 5-HT(1A) receptors in learning and memory.
Behav Brain Res. 2008; 195(1): 54–77.
Savitz, J, Lucki, I, Drevets, WC. 5-HT1A receptor function in major depressive disorder. Prog Neurobiol. 2009; 88(1): 17–31.
Drago, A, De Ronchi, D, Serretti, A. 5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Int J Neuropsychopharmacol. 2008; 11(5): 701–721.
Kuffel, A, Eikelmann, S, Terfehr, K, et al. Noradrenergic blockade and memory in patients with major depression and healthy participants. Psychoneuroendocrinology. 2013; 40: 86–90.
Pehrson, AL, Sanchez, C.. Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction. CNS Spectr. 2014; 19(2): 121–133.
Bosia, M, Anselmetti, S, Bechi, M, et al. Effect of 5-HT1A-receptor functional polymorphism on Theory of Mind performances in schizophrenia.
Psychiatry Res. 2011; 188(2): 187–190.
Terzić, T, Kastelic, M, Dolžan, V, Plesničar, BK. Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia. Neuropsychiatr Dis Treat. 2015; 11: 453–459.
Albert, PR, Le François, B, Millar, AM. Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness. Mol Brain. 2011; 4: 21.
Drevets, WC, Thase, ME, Moses-Kolko, EL, et al. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol. 2007; 34(7): 865–877.
Boldrini, M, Underwood, MD, Mann, JJ, Arango, V
. Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res. 2008; 42(6): 433–442.
Guy, W. ed. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration; 1976.
Sheehan, DV. The Sheehan Disability Scales. In. The Anxiety Disease and How to Overcome It. New York: Charles Scribner and Sons; 1983. 151.
Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23: 56–62.
Ferguson, JM, Wesnes, KA, Schwartz, GE. Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients. Int Clin Psychopharmacol. 2003; 18(1): 9–14.
Reddy, S, Focht, K, Musgnung, J, Edgar, C, Gucio-Pabia, CJ, Wesnes, KA. The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder. Presented at the ISCTM Annual Meeting, October 13–14, 2010, Baltimore, MD. https://isctm.org/public_access/2010_13Oct_Posters_Abstracts.pdf.
Wesnes, KA, Ward, T, McGinty, A, Petrini, O. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle aged volunteers. Psychopharmacology (Berl). 2000; 152(4): 353–361.
Wesnes, KA, Luthringer, R, Ambrosetti, L, et al. The effects of a combination of Panax ginseng, vitamins and minerals on mental performance, mood and physical fatigue in nurses working night shifts: a double-blind, placebo controlled trial. Current Topics in Nutraceutical Research. 2003; 1: 169–174.
Wesnes, KA, Pincock, C. Practice effects on cognitive tasks: a major problem?
Lancet Neurol. 2002; 1(8): 473.
Frey, PW, Colliver, JA. Sensitivity and responsiveness measures for discrimination learning. Learning and Motivation. 1973; 4(3): 327–342.
Albert, PR, Lemonde, S. 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist. 2004; 10(6): 575–593.
Schatzberg, AF, Nemeroff, CB eds. The American Psychiatric Publishing Textbook of Psychopharmacology, 4th ed.. Washington, DC: American Psychiatric Publishing; 2009.
Miller, JM, Hesselgrave, N, Ogden, RT, et al. Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder. Biol Psychiatry. 2013; 74(10): 760–776.
Parsey, RV, Olvet, DM, Oquendo, MA, et al. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology. 2006; 31(8): 1745–1749.
Meeter, M, Talamini, L, Schmitt, JAJ, Riedel, WJ. Effects of 5-HT on memory and the hippocampus: model and data. Neuropsychopharmacology. 2006; 31(4): 712–720.
McIntyre, RS, Lophaven, S, Olsen, CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014; 17(10): 1557–1567.